Small peptide therapeutics are one of the fastest-growing segments in drug development and manufacturing, driven by the explosive success of GLP-1 receptor agonists and a deep pipeline of candidates across metabolic disease, oncology, and beyond
Building muscle is important because it supports metabolism, strength, and sustainable weight loss, Obici says
Patients who lose the most weight typically walk 150+ minutes per week, prioritize protein intake, and drink sufficient water to support metabolism and reduce false hunger signals
10.1054/npep.1999.0017 76
Survodutide (BI 456906) is another promising dual GLP-1R/GCGR agonist under development for the treatment of T2D, obesity, and NASH
Evidence-based approaches to weight loss address the fundamental behaviours and patterns that influence weight, rather than promising magic solutions